# Evaluate Ltd

> Analysis by Optimly for Optimly AI Visibility, in the Optimly AI Brand Index. Last analyzed August 9, 2026.

> Evaluate Ltd empowers global pharma and biotech leaders with trusted data, insights, and AI-driven intelligence to support strategic, commercial, and investment decisions.

- Business Profile: https://optimly.ai/brand/evaluate-ltd
- Publisher: Optimly (https://optimly.ai)
- Dataset: Optimly AI Brand Index (https://optimly.ai/brand)
- Official website: https://evaluate.com/
- Logo: https://logo.clearbit.com/evaluate.com
- Slug: evaluate-ltd
- Brand Authority Index tier: Emerging
- Archetype: Incumbent
- Category: Pharmaceutical & Biotech
- Last Analyzed: August 9, 2026

## Buyer Intent Signals
Problems: In-house Market Research Team: Companies can rely on their internal teams to manually collect, analyze, and interpret market data using publicly available sources, leading to slower insights and highe | Specialized Pharma Consulting Firms: Engaging external consulting agencies for bespoke market analysis, forecasting, and competitive intelligence. This offers tailored insights but can be costly and l | Rely on Publicly Available Information: Companies may opt to make decisions based solely on free, publicly available reports, news, and limited internal data, risking incomplete or outdated informatio
Solutions: Evaluate Ltd pharma intelligence | Evaluate Pharma market forecasts | Ask Ella AI pharma | Biomedtracker drug development | Norstella Atlas competitive intelligence | General Business Intelligence Platforms with Custom Integrations: Using generic BI tools (e.g., Tableau, Power BI) and attempting to integrate disparate pharma data sources. This requires significant